Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Launch date
Market cap
-
Enterprise valuation
€73—109m (Dealroom.co estimates Nov 2012.)
Mountain View California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$6.2m | Series A | ||
| N/A | $4.3m | Series B | |
| N/A | $2.8m | Series C | |
| N/A | $3.0m | Series D | |
| N/A | $250k | Seed | |
| N/A | $4.1m | Series E | |
$20.0m | Series F | ||
$50.0m | Growth Equity VC | ||
| Total Funding | €82.4m | ||